The Brixen Proteomics Summer School is back! Speaker list is already looking strong!

Structures of the fusion glycoprotein from respiratory syncytial virus (RSV) were used to engineer effective vaccines to fight viral infection More at PDB-101:

‘Somni,’ our most ambitious album to date, made possible by a team of over one hundred musicians, engineers, videographers, lighting specialists, and production crew, is finally out worldwide. https://t.co/rkU8YCxD0O

On my way to the @denvms fall meeting to present our antibody sequencing work 😁

On my way to Leiden for the annual @ICI_NL conference 😁

A groundbreaking paper by @younis_sh1 et al. @stanfordimmuno provides an answer to the long-standing question about how EBV infections are linked to lupus. A short thread to explain the key findings. (1/) https://t.co/dUpz19IjEv

Delighted to share the peer-reviewed version of our article describing a prefusion-stabilized MARV GP vaccine immunogen and a best-in-class MARV neutralizing and protective antibody! Led by Amin Addetia with @VirBiotech @HHMINEWS https://t.co/SI78iXWkef

🌞

History.

This recent article in @JVirology is a treat for researchers with interest in #picornaviruses. The team @mihnea_bostina Lab reconstructed essentially all intermediate states of uncoating of the oncolytic Seneca Valley Virus from only a few hundred electron micrographs.

Thrilled, and admittedly relieved, to see this major investment in Dutch #cryoEM become reality! 🇳🇱🔬 Honoured to be a co-applicant on this national initiative and very excited for the opportunity to advance our work in cellular structural virology! https://t.co/PhbGCUvxk5

Hot off the presses and 5 years in the making – our first step toward building a synthetic carboxysome is out in @NatureComms An amazing collab between @SydneyChemistry @ARC_CoESB and @ourANU:

Mijn stem ging naar @sarahdobbe @SPnl.

STEMMEN!!!

✧ 𝘏𝘦𝘭𝘭𝘰 𝘜𝘴𝘦𝘳𝘴! 𝘞𝘦 𝘢𝘳𝘦 𝘤𝘰𝘮𝘪𝘯𝘨 𝘣𝘢𝘤𝘬 𝘧𝘰𝘳 𝘢 𝘧𝘦𝘸 𝘴𝘩𝘰𝘸𝘴 𝘪𝘯 𝘌𝘶𝘳𝘰𝘱𝘦 𝘪𝘯 𝘋𝘦𝘤𝘦𝘮𝘣𝘦𝘳, 𝘴𝘵𝘰𝘬𝘦𝘥 𝘵𝘰 𝘣𝘦 𝘱𝘭𝘢𝘺𝘪𝘯𝘨 𝘪𝘯 𝘵𝘩𝘦 𝘜𝘯𝘪𝘵𝘦𝘥 𝘒𝘪𝘯𝘨𝘥𝘰𝘮 𝘧𝘰𝘳 𝘵𝘩𝘦 𝘧𝘪𝘳𝘴𝘵 𝘵𝘪𝘮𝘦! 𝘴𝘦𝘦 𝘺𝘰𝘶 𝘴𝘰𝘰𝘯 ✧ 🇳🇱🇬🇧🇫🇷

New preprint! "An engineered closed-shell, two-component, 480-subunit nucleocapsid" https://t.co/MFyHx78TS3 Thanks to all co-authors! @Mik_Levasseur @AngelaSteinauer @stetter19

Happy to share that our paper on the PlPVC1 eCIS is out in @NatureComms 🥳 Congratulations to first author Leyre Marín-Arraiza and all co-authors! #cryoEM @cryoEM_Papers @UCPH_CPR

Welcome to flu season. Influenza Neuraminidase is an important target for influenza drugs More at PDB-101: https://t.co/IjJXt5QXI4

Evolution of Ab cross-reactivity to influenza H5N1 NA: New work isolates & characterizes protective antibody against influenza neuraminidase that acquires cross-reactivity to avian H5N1 as a byproduct of affinity maturation against human H3N2 @wchnicholas https://t.co/RGeirbO2ER

Atypical viral latency🦠⏱️ has been found for Ebola virus (known to only induce acute infection in human), again! Our latest preprint on viral condensate prolonging residential RNA half-life may provide a clue. See 📄 https://t.co/tcHIgNNqK0